Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12
  2. Amlin-Van Schaick, J. C.; Kim, S.; DiFabio, C.; Lee, M. H.; Broman, K. W.; Reilly, K. M.
  3. Neuro-Oncology. 2012, Feb; 14(2): 160-174.
  1. 2.   The Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity In vitro and In vivo
  2. Banerjee, S.; Byrd, J. N.; Gianino, S. M.; Harpstrite, S. E.; Rodriguez, F. J.; Tuskan, R. G.; Reilly, K. M.; Piwnica-Worms, D. R.; Gutmann, D. H.
  3. Cancer Research. 2010, Feb; 70(4): 1356-1366.
  1. 3.   Bioluminescent Approaches for Measuring Tumor Growth in a Mouse Model of Neurofibromatosis
  2. Hawes, J. J.; Reilly, K. M.
  3. Toxicologic Pathology. 2010, Jan; 38(1): 123-130.
  1. 4.   A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors
  2. Chen, J. H.; Yao, X. H.; Gong, W.; Hu, J.; Zhou, X. D.; Chen, K.; Liu, H.; Ping, Y. F.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Sep; 84(3): 223-231.
  1. 5.   Phase I trial of temozolomide plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma
  2. Quinn, J. A.; Desjardins, A.; Weingart, J.; Brem, H.; Dolan, M. E.; Delaney, S. M.; Vredenburgh, J.; Rich, J.; Friedman, A. H.; Reardon, D. A.; Sampson, J. H.; Pegg, A. E.; Moschel, R. C.; Birch, R.; McLendon, R. E.; Provenzale, J. M.; Gururangan, S.; Dancey, J. E.; Maxwell, J.; Tourt-Uhlig, S.; Herndon, J. E.; Bigner, D. D.; Friedman, H. S.
  3. Journal of Clinical Oncology. 2005, OCT 1; 23(28): 7178-7187.
  1. 6.   The importance of genome architecture in cancer susceptibility - Location, location, location
  2. Reilly, K. M.
  3. Cell Cycle. 2004, NOV; 3(11): 1378-1382.
  1. 7.   The p16/Cdkn2a/Ink4a gene is frequently deleted in nitrosourea-induced rat glial tumors
  2. Schlegel, J.; Piontek, G.; Kersting, M.; Schuermann, M.; Kappler, R.; Scherthan, H.; Weghorst, C.; Buzard, G.; Mennel, H. D.
  3. Pathobiology. 1999 67(4): 202-206.
  1. 8.   Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity
  2. Ali, I. U.; Schriml, L. M.; Dean, M.
  3. Journal of the National Cancer Institute. 1999 91(22): 1922-1932.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel